معرفی
Hugh Watkins is a Radcliffe Professor of Medicine at the University of Oxford, specializing in Cardiovascular Medicine. His research focuses on the molecular genetics of inherited heart diseases, particularly hypertrophic cardiomyopathy (HCM), and coronary artery disease. He leads the Watkins Group within the Inherited Heart Disease Service and serves as Principal Investigator of the CureHeart project.
- Education: Not explicitly mentioned
- Key Collaborators: Dr. Charles Redwood, Dr. Houman Ashrafian
Research Interests: Watkins investigates genetic mechanisms in cardiovascular diseases, including:
- Energy compromise in HCM and therapeutic interventions
- Role of Lp(a) lipoprotein in coronary disease
- Genome-wide association studies (GWAS) for disease susceptibility
- Proteomic profiling of HCM phenotypes
- AI applications in cardiac diagnostics
- Functional genomics for novel therapeutic targets
Article Trends: Recent publications emphasize:
- Genetic loci in HCM and coronary disease
- Proteomic biomarkers for risk stratification
- Novel therapies like cardiac myosin inhibitors
- Population-level genomic analysis
- Computational modeling of arrhythmias
Scientific Awards:
- Fellow of the Royal Society (FRS)
- Fellow of the Academy of Medical Sciences (FMedSci)
Leadership: He chairs the international C4D Consortium for coronary artery disease research and pioneered the NHS national DNA diagnostic service for sudden cardiac death syndromes. His work bridges basic science (molecular genetics, model organisms) and clinical translation.
Labs/Teams: Leads the Watkins Group at Oxford, collaborating closely with Dr. Charles Redwood and Dr. Houman Ashrafian. Involved in the HCM Registry and CureHeart initiatives.